Principal Financial Group Inc. Has $56.01 Million Holdings in Privia Health Group, Inc. $PRVA

Principal Financial Group Inc. trimmed its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 2.3% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,723,073 shares of the company’s stock after selling 64,729 shares during the period. Principal Financial Group Inc.’s holdings in Privia Health Group were worth $56,014,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of PRVA. Bayban acquired a new position in shares of Privia Health Group during the 4th quarter valued at $26,000. Hantz Financial Services Inc. increased its stake in Privia Health Group by 456.2% in the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after purchasing an additional 926 shares in the last quarter. Global Retirement Partners LLC increased its stake in Privia Health Group by 579.8% in the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after purchasing an additional 1,351 shares in the last quarter. Canada Pension Plan Investment Board raised its holdings in shares of Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after purchasing an additional 1,200 shares during the period. Finally, Kestra Advisory Services LLC acquired a new position in shares of Privia Health Group during the fourth quarter valued at about $93,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Insider Buying and Selling

In other Privia Health Group news, CFO David Mountcastle sold 21,275 shares of the business’s stock in a transaction that occurred on Thursday, July 9th. The stock was sold at an average price of $27.67, for a total transaction of $588,679.25. Following the completion of the sale, the chief financial officer directly owned 164,853 shares of the company’s stock, valued at approximately $4,561,482.51. The trade was a 11.43% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Matthew Shawn Morris sold 53,722 shares of the business’s stock in a transaction that occurred on Monday, July 6th. The stock was sold at an average price of $27.24, for a total value of $1,463,387.28. Following the sale, the director directly owned 68,188 shares of the company’s stock, valued at $1,857,441.12. This represents a 44.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 478,855 shares of company stock worth $12,099,109 in the last quarter. Insiders own 5.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on PRVA shares. Evercore set a $26.00 target price on Privia Health Group in a research note on Wednesday, April 8th. Barclays dropped their price target on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Canaccord Genuity Group cut their price target on Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Weiss Ratings raised Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 2nd. Finally, Zacks Research downgraded Privia Health Group from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 7th. Eleven equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Privia Health Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $31.15.

Privia Health Group Price Performance

Shares of NASDAQ PRVA opened at $26.90 on Friday. The stock has a market capitalization of $3.39 billion, a P/E ratio of 168.14, a P/E/G ratio of 2.15 and a beta of 0.83. The company has a 50-day moving average price of $24.12 and a 200-day moving average price of $23.27. Privia Health Group, Inc. has a 1 year low of $18.77 and a 1 year high of $28.82.

Privia Health Group Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.